Latest News & Features

Reset all filters
Article Type
Channels & Sectors

Refine Search
Japanese imaging and electronics firm has acquired non-exclusive licence from ERS Genomics | Technology will be used by Elixirgen Scientific, acquired by Ricoh in 2022.   14 March 2024
Big Pharma
Pharma company’s new partnership is an “opportunity” to accelerate access and maximise the potential of AstraZenica’s asthma drug | Delhi-based pharma firm will provide valuable distribution channels.   12 March 2024
Big Pharma
Danish drugmaker testing suspect products and assisting with legal cases | High demand and global shortages have driven surge in weight-loss drug fakes.   12 March 2024
Big Pharma
WTO members failed to reach consensus on whether to expand patent waiver agreed in 2022 | Extended proposal would include tests and treatments for COVID-19.   7 March 2024
‘Creative litigation strategist’ will expand firm’s capacity in complex technology areas | New hire joins from LTL Attorneys and spent much of career at Quinn Emanuel.   7 March 2024
Firm hires former Food and Drug Administration staffer from King & Spalding | Washington DC office gains nearly a decade of FDA experience.   5 March 2024
The drama of the decade-long patent dispute reflects a changing market. Marisa Woutersen speaks with John Cronin and Pete Conley from Know Labs to explore its impact on patent strategy and the changing face of medtech.   5 March 2024
US medical device company alleges Catalyst Orthoscience infringed patent through reverse shoulder surgery system | Firm seeks to enforce a patent granted in October last year.   29 February 2024
Big Pharma
Firm wishes to avoid ‘protracted litigation’ with confidential settlement | Counsel for GSK told Delaware judge in January that lawsuits are ‘way ahead of the science’.   29 February 2024
Partner with extensive patent litigation experience joins London office | A&O is finalising merger with Shearman & Sterling.   28 February 2024